Leukocyte Surface Antigen CD47 Market Report

Global and Region Leukocyte Surface Antigen CD47 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：198
  • REPORT CODE：GMM947862
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Leukocyte Surface Antigen CD47 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Leukocyte Surface Antigen CD47market, defines the market attractiveness level of Leukocyte Surface Antigen CD47 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Leukocyte Surface Antigen CD47 industry, describes the types of Leukocyte Surface Antigen CD47 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Leukocyte Surface Antigen CD47 market and the development prospects and opportunities of Leukocyte Surface Antigen CD47 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Leukocyte Surface Antigen CD47 market in Chapter 13.

    By Player:

    • Trillium Therapeutics Inc

    • Aurigene Discovery Technologies Ltd

    • Forty Seven Inc

    • Surface Oncology Inc

    • Celgene Corp

    By Type:

    • B-6H12

    • ALX-148

    • CC-90002

    • PSTx-23

    • Others

    By End-User:

    • Lymphoma

    • Ovarian Cancer

    • Ischemia Reperfusion Injury

    • Kindney Transplant Rejection

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Leukocyte Surface Antigen CD47 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Leukocyte Surface Antigen CD47 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Leukocyte Surface Antigen CD47 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Leukocyte Surface Antigen CD47 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Leukocyte Surface Antigen CD47 Market Analysis and Outlook to 2022

    • 7.1 Global Leukocyte Surface Antigen CD47 Consumption (2017-2022)

    • 7.2 United States Leukocyte Surface Antigen CD47 Consumption (2017-2022)

    • 7.3 Europe Leukocyte Surface Antigen CD47 Consumption (2017-2022)

    • 7.4 China Leukocyte Surface Antigen CD47 Consumption (2017-2022)

    • 7.5 Japan Leukocyte Surface Antigen CD47 Consumption (2017-2022)

    • 7.6 India Leukocyte Surface Antigen CD47 Consumption (2017-2022)

    • 7.7 South Korea Leukocyte Surface Antigen CD47 Consumption (2017-2022)

    8 Region and Country-wise Leukocyte Surface Antigen CD47 Market Analysis and Outlook to 2028

    • 8.1 Global Leukocyte Surface Antigen CD47 Consumption Forecast (2022-2028)

    • 8.2 United States Leukocyte Surface Antigen CD47 Consumption Forecast (2022-2028)

    • 8.3 Europe Leukocyte Surface Antigen CD47 Consumption Forecast (2022-2028)

    • 8.4 China Leukocyte Surface Antigen CD47 Consumption Forecast (2022-2028)

    • 8.5 Japan Leukocyte Surface Antigen CD47 Consumption Forecast (2022-2028)

    • 8.6 India Leukocyte Surface Antigen CD47 Consumption Forecast (2022-2028)

    • 8.7 South Korea Leukocyte Surface Antigen CD47 Consumption Forecast (2022-2028)

    9 Global Leukocyte Surface Antigen CD47 Market Outlook by Types and Applications to 2022

    • 9.1 Global Leukocyte Surface Antigen CD47 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global B-6H12 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ALX-148 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CC-90002 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global PSTx-23 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Leukocyte Surface Antigen CD47 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Lymphoma Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ischemia Reperfusion Injury Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Kindney Transplant Rejection Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Leukocyte Surface Antigen CD47 Market Outlook by Types and Applications to 2028

    • 10.1 Global Leukocyte Surface Antigen CD47 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global B-6H12 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global ALX-148 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CC-90002 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global PSTx-23 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Leukocyte Surface Antigen CD47 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Ischemia Reperfusion Injury Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Kindney Transplant Rejection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Leukocyte Surface Antigen CD47 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Leukocyte Surface Antigen CD47 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Leukocyte Surface Antigen CD47 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Leukocyte Surface Antigen CD47 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Leukocyte Surface Antigen CD47 Market Competitive Analysis

    • 14.1 Trillium Therapeutics Inc

      • 14.1.1 Trillium Therapeutics Inc Company Details

      • 14.1.2 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product and Service

    • 14.2 Aurigene Discovery Technologies Ltd

      • 14.2.1 Aurigene Discovery Technologies Ltd Company Details

      • 14.2.2 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product and Service

    • 14.3 Forty Seven Inc

      • 14.3.1 Forty Seven Inc Company Details

      • 14.3.2 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Product and Service

    • 14.4 Surface Oncology Inc

      • 14.4.1 Surface Oncology Inc Company Details

      • 14.4.2 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product and Service

    • 14.5 Celgene Corp

      • 14.5.1 Celgene Corp Company Details

      • 14.5.2 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Celgene Corp Leukocyte Surface Antigen CD47 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Leukocyte Surface Antigen CD47

    • Figure Leukocyte Surface Antigen CD47 Picture

    • Table Global Leukocyte Surface Antigen CD47 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Leukocyte Surface Antigen CD47 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Leukocyte Surface Antigen CD47 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Leukocyte Surface Antigen CD47 Consumption by Country (2017-2022)

    • Figure United States Leukocyte Surface Antigen CD47 Consumption and Growth Rate (2017-2022)

    • Table Europe Leukocyte Surface Antigen CD47 Consumption and Growth Rate (2017-2022)

    • Figure China Leukocyte Surface Antigen CD47 Consumption and Growth Rate (2017-2022)

    • Figure Japan Leukocyte Surface Antigen CD47 Consumption and Growth Rate (2017-2022)

    • Figure India Leukocyte Surface Antigen CD47 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Leukocyte Surface Antigen CD47 Consumption and Growth Rate (2017-2022)

    • Figure Global Leukocyte Surface Antigen CD47 Consumption Forecast by Country (2022-2028)

    • Figure United States Leukocyte Surface Antigen CD47 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Leukocyte Surface Antigen CD47 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Leukocyte Surface Antigen CD47 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Leukocyte Surface Antigen CD47 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Leukocyte Surface Antigen CD47 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Leukocyte Surface Antigen CD47 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global B-6H12 Consumption and Growth Rate (2017-2022)

    • Figure Global ALX-148 Consumption and Growth Rate (2017-2022)

    • Figure Global CC-90002 Consumption and Growth Rate (2017-2022)

    • Figure Global PSTx-23 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Ischemia Reperfusion Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Kindney Transplant Rejection Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global B-6H12 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ALX-148 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CC-90002 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PSTx-23 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ischemia Reperfusion Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kindney Transplant Rejection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Leukocyte Surface Antigen CD47 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Leukocyte Surface Antigen CD47 Export by Region (Top 5 Countries) (2017-2028)

    • Table Trillium Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product and Service

    • Table Aurigene Discovery Technologies Ltd (Foundation Year, Company Profile and etc.)

    • Table Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product and Service

    • Table Forty Seven Inc (Foundation Year, Company Profile and etc.)

    • Table Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Forty Seven Inc Leukocyte Surface Antigen CD47 Product and Service

    • Table Surface Oncology Inc (Foundation Year, Company Profile and etc.)

    • Table Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Surface Oncology Inc Leukocyte Surface Antigen CD47 Product and Service

    • Table Celgene Corp (Foundation Year, Company Profile and etc.)

    • Table Celgene Corp Leukocyte Surface Antigen CD47 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corp Leukocyte Surface Antigen CD47 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US